Yu Yong joined the Alibaba family in 2005 and boasts a rich, two-decade-long career in the consumer and e-commerce realms. He possesses profound knowledge in merchant operations and has spearheaded numerous supply chain transformation initiatives. Meanwhile, Shen Difan will be working alongside Wu Yongming within the Alibaba Group, with a shared focus on delving into the potential applications of artificial intelligence in the biomedical sector. According to Ali Health's financial results announcement for the fiscal year 2026, as of March 31, 2026, the company's revenue soared to RMB 34.255 billion, marking a 12% year-on-year increase. Its net profit also witnessed a significant uptick, reaching RMB 1.936 billion, up by 35.2% from the previous year. Furthermore, Ali Health has unveiled a fresh strategic blueprint, driven by a dual-pronged approach that combines 'comprehensive pharmaceutical services with medical AI'.